(Total Views: 672)
Posted On: 08/07/2025 5:35:06 AM
Post# of 155687
From 2020 with Pestell -- " In analysis of >2,200 breast cancer patients, >50% of patient’s tumors were CCR5+ and >95% of triple negative breast cancer (TNBC) were CCR5+ (4). Higher cytoplasmic CCR5 staining correlated with poor prognosis (5). "
https://pmc.ncbi.nlm.nih.gov/articles/PMC6810651/
Leronlimab will come into play @ 1 stage or another....
https://pmc.ncbi.nlm.nih.gov/articles/PMC6810651/
Leronlimab will come into play @ 1 stage or another....
(6)
(0)
